<DOC>
	<DOCNO>NCT02741700</DOCNO>
	<brief_summary>The objective test efficacy patient-centered , culturally relevant narrative intervention , `` storytelling , '' base solid conceptual foundation narrative communication theory construct Health Belief Model ( HBM ) improve medication adherence outcomes chronic disease among African-Americans ( AA ) , use gout example . Gout chronic disease associate chronic symptom disability interrupt intermittent acute flare , similar Chronic Obstructive Pulmonary Disease ( COPD ) Congestive Heart Failure ( CHF ) lead joint destruction treat appropriately . Due intermittently symptomatic nature chronic condition , patient often n't perceive disease severity susceptibility disease complication , , therefore , may balance barrier benefit medication adherence . Storytelling patient ' voice power directly effectively confront patient 's barrier medication adherence , reinforce benefit provide useful cue action . Storytelling promotes patient engagement patient identifies storyteller lead patient 's recognition need treat condition improve health outcome , show meaningful improvement blood pressure recent clinical trial AAs hypertension . The success project , combine publish data , represent major step toward demonstrate effectiveness storytelling improve medication adherence chronic disease address two VA research priority area , i.e. , health care disparities health care delivery .</brief_summary>
	<brief_title>SToRytelling Improve DiseasE Outcomes GOut : The STRIDE-GO 2 Study</brief_title>
	<detailed_description>The investigator conduct 12-month , multicenter , randomize control trial among 250 African-American Veterans gout ULT medication possession ratio &lt; 80 % Birmingham , St. Louis Philadelphia VA clinic . The investigator compare efficacy storytelling intervention usual care improve Urate Lowering Therapy ( ULT ) adherence , assess MEMSCaps ( electronic monitoring ) 6-months ( primary outcome ) ; reduce gout flare need treatment , improve patient satisfaction , improve ability achieve target serum urate &lt; 6 mg/dl improve self-reported ULT adherence 6-months ( secondary outcome ) . The investigator assess outcomes 12-months evidence sustenance effect intervention . Alignment VA mission priority : This study serve VA 's mission improve health Veterans address two priority area , 1 ) decrease health care disparities 2 ) improve health care delivery use low-cost , technology-based solution poor medication adherence . Study result lead ready-to-implement low cost patient-centered intervention AA Veterans gout improve medication adherence patient outcomes . This study provide proof efficacy `` storytelling '' improve medication adherence chronic symptomatic disease . The `` storytelling '' intervention easily adapt similar chronic symptomatic condition COPD CHF .</detailed_description>
	<mesh_term>Gout</mesh_term>
	<criteria>African American Veteran Patients Gout low medication adherence , define average allopurinol MPR &lt; 0.80 , base immediately prior period 180days ( low adherers ) . participant Optout research contact . high allopurinol adherence enrol</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Adherence</keyword>
	<keyword>Disparities</keyword>
	<keyword>Patient Outcomes</keyword>
</DOC>